Learn more about Tandem Diabetes' t:slim X2 and Mobi AID insulin pumps and future devices.
News
+2
/
Aug 18, 2025
Tandem’s SteadiSet 7-day infusion set received FDA 510(k) clearance and is expected to release on multiple pumps next year.
Tandem Mobi
+3
Aug 12, 2025
I’m on a mission to try every insulin pump on the market. Here’s how Tandem Mobi—and its Control-IQ+ algorithm—fit into my life over three months of daily use.
Jul 29, 2025
The tubeless add-on for Tandem's Mobi insulin pump will give users an untethered wear option and challenge competitors to innovate faster.
Jul 22, 2025
Tandem’s SteadiSet received FDA 510(k) clearance for 7-day wear and is expected to release in 2026 for multiple pumps.
Jun 20, 2025
Abbott’s flagship CGM now powers Tandem’s Control-IQ+ system—with more pump integrations and a ketone sensor on the horizon.
CGM
+7
Tandem, Beta Bionics, Sequel Med Tech, and Ypsomed are the first to announce integration plans for Abbott’s dual-analyte sensor with more expected.
Jun 9, 2025
Tandem Diabetes is already telling patients its smartphone app to control the Mobi insulin pump will arrive by the end of 2025.
Tandem
+4
May 30, 2025
After three years with Omnipod, a tubed pump taught me something new about tech—and myself
May 16, 2025
The switch from a tubeless to a tubed pump had its challenges.
Apr 1, 2025
Control-IQ+ Technology expands access and flexibility for stronger diabetes management
